Drug Discovery World

JANUARY 9, 2024

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. The therapy has shown positive results in Phase III trials in both breast and lung cancer.

Drugs 173

Drugs Therapies Treatment Virus 173

Vial

MARCH 1, 2024

Leading Global CROs To advance new therapies, pharma, biotech, and medical device sponsors engage CROs to help navigate the complex landscape of drug development and regulatory pathways and to manage clinical trials efficiently, ethically, and in compliance with good clinical practice ( GCP ) standards. billion by 2029.

Clinical Trials 52

Clinical Trials Clinical Research Laboratories Trials 52

Drug Discovery World

JULY 26, 2024

With an anticipated annual growth rate of 7.61%, they are predicted to reach US$12.57bn by 2029. Artificial intelligence (AI) in both machine learning and generative AI, is revolutionising the industry, with companies like InSilico Medicine and Relay Therapeutics leading the charge, accelerating the drug development process.

Science 130

Science Government Biosimilars Marketing 130